Tymlos Generic Name & Formulations
Postmenopausal women with osteoporosis at high risk for fracture or patients who have failed or are intolerant to other available osteoporosis therapy. To increase bone density in men with osteoporosis at high risk for fracture or patients who have failed or are intolerant to other available osteoporosis therapy.
Tymlos Dosage and Administration
80mcg SC once daily into periumbilical region of abdomen; rotate inj sites. Give supplemental calcium and vitamin D if dietary intake inadequate. Cumulative use >2yrs not recommended.
Tymlos Boxed Warnings
Renal. Half-life: 1.7 hours.
Tymlos Adverse Reactions
Postmenopausal women: hypercalciuria, dizziness, nausea, headache, palpitations, fatigue, upper abdominal pain, vertigo; Men: inj site reactions (erythema, swelling, pain), dizziness, arthralgia, contusion, nausea, diarrhea, abdominal distention/pain, bone pain; orthostatic hypotension, hypercalcemia, urolithiasis.
Tymlos Clinical Trials
Tymlos Patient Counseling